Efficient generation of multipotent mesenchymal stem cells from umbilical cord blood in stroma-free liquid culture

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Peters, Rowayda ^a   Wolf, Monika J ^b   van den Broek, Maries ^a   Nuvolone, Mario ^b,e   Dannenmann, Stefanie ^a   Stieger, Bruno ^a   Rapold, Reto ^c   Konrad, Daniel ^c   Rubin, Arnold ^d   Bertino, Joseph R ^d   Aguzzi, Adriano ^b   Heikenwalder, Mathias ^b,f   Knuth, Alexander K ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PAVIA   (Italy)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD133 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; FLT3 LIGAND; HERMES ANTIGEN; INTERLEUKIN 6; MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; NESTIN; RECOMBINANT STEM CELL FACTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN; STEM CELL FACTOR;

ARTICLE; CD34 SELECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL RENEWAL; CELL STRUCTURE; COLONY FORMING UNIT F; CONTROLLED STUDY; CRYOPRESERVATION; CULTURE TECHNIQUE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LIQUID CULTURE; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PLURIPOTENT STEM CELL; STEM CELL EXPANSION; UMBILICAL CORD BLOOD; BIOSYNTHESIS; CELL FREE SYSTEM; CYTOLOGY; FETUS BLOOD; METABOLISM; METHODOLOGY; STEM CELL; UMBILICAL CORD;

ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELL-FREE SYSTEM; CYTOKINES; EPIDERMAL GROWTH FACTOR; FETAL BLOOD; FIBROBLAST GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERLEUKIN-6; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; STEM CELL FACTOR; STEM CELLS; UMBILICAL CORD;

EID: 78651237401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015689     Document Type: Article

References (52)

1. Kulterer B, Friedl G, Jandrositz A, Sanchez-Cabo F, Prokesch A, et al. (2007) Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics 8: 70.
2. Bron D, De Bruyn C, Balasse H, Ley P, De Hemptinne D, et al. (2008) [Cord blood: from bench to bedside]. Bull Cancer 95: 314-319.
3. Bieback K, Kern S, Kluter H, Eichler H (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22: 625-634.
4. Pozzi S, Lisini D, Podesta M, Bernardo ME, Sessarego N, et al. (2006) Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. Exp Hematol 34: 934-942.
5. Rocha V, Sanz G, Gluckman E (2004) Umbilical cord blood transplantation. Curr Opin Hematol 11: 375-385.
6. Hough R, Cooper N, Veys P (2009) Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available? Br J Haematol 147: 593-613.
7. Oda M, Isoyama K, Ito E, Inoue M, Tsuchida M, et al. (2009) Survival after cord blood transplantation from unrelated donor as a second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Int J Hematol 89: 374-382.
8. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
9. Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, et al. (2002) Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 109: 1291-1302.
10. Lee OK, Kuo TK, Chen WM, Lee KD, Hsieh SL, et al. (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103: 1669-1675.
11. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, et al. (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416.
12. Castro-Malaspina H, Gay RE, Resnick G, Kapoor N, Meyers P, et al. (1980) Characterization of human bone marrow fibroblast colony-forming cells (CFUF) and their progeny. Blood 56: 289-301.
13. Rojewski M, Weber B, Schrezenmeier H (2008) Phenotypic Characterization of Mesenchymal Stem Cells from Various Tissues. Transfusion Medicine and Hemotherapy 35: 168-184.
14. Hematti P (2008) Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) 22: 262-273.
15. Valtieri M, Sorrentino A (2008) The mesenchymal stromal cell contribution to homeostasis. J Cell Physiol 217: 296-300.
16. Cho KA, Ju SY, Cho SJ, Jung YJ, Woo SY, et al. (2009) Mesenchymal stem cells showed the highest potential for the regeneration of injured liver tissue compared with other subpopulations of the bone marrow. Cell Biol Int 33: 772-777.
17. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B, et al. (2003) Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not. Br J Haematol 121: 368-374.
18. Perdikogianni C, Dimitriou H, Stiakaki E, Martimianaki G, Kalmanti M (2008) Could cord blood be a source of mesenchymal stromal cells for clinical use? Cytotherapy 10: 452-459.
19. Solves P, Mirabet V, Planelles D, Carbonell-Uberos F, Roig R (2008) Influence of volume reduction and cryopreservation methodologies on quality of thawed umbilical cord blood units for transplantation. Cryobiology 56: 152-158.
20. Stieger B, Peters R, Sidler MA, Meier PJ (2006) Hepatocyte transplantation: potential of hepatocyte progenitor cells and bone marrow derived stem cells. Swiss Med Wkly 136: 552-556.
21. Rebelatto CK, Aguiar AM, Moretao MP, Senegaglia AC, Hansen P, et al. (2008) Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Exp Biol Med (Maywood) 233: 901-913.
22. Perey L, Peters R, Pampallona S, Schneider P, Gross N, et al. (1998) Extensive phenotypic analysis of CD34 subsets in successive collections of mobilized peripheral blood progenitors. Br J Haematol 103: 618-629.
23. Peters R, Leyvraz S, Perey L (1998) Apoptotic regulation in primitive hematopoietic precursors. Blood 92: 2041-2052.
24. Peters R, Leyvraz S, Faes-Van't Hull E, Jaunin P, Gerber S, et al. (2002) Longterm ex vivo expansion of human fetal liver primitive haematopoietic progenitor cells in stroma-free cultures. Br J Haematol 119: 792-802.
25. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L (1995) Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 333: 283-287.
26. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, et al. (1997) Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 89: 2644-2653.
27. Piacibello W, Sanavio F, Severino A, Dane A, Gammaitoni L, et al. (1999) Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood 93: 3736-3749.
28. Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, et al. (2010) Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation. Am J Obstet Gynecol 202: 193 e191-193 e113.
29. Fang B, Song Y, Li N, Li J, Han Q, et al. (2009) Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Annals of Hematology 88: 261-266.
30. He Q, Wan C, Li G (2007) Concise review: multipotent mesenchymal stromal cells in blood. Stem Cells 25: 69-77.
31. Friedenstein AJ, Latzinik NV, Gorskaya Yu F, Luria EA, Moskvina IL (1992) Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner 18: 199-213.
32. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E, et al. (2001) Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood. Haematologica 86: 1099-1100.
33. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, et al. (2006) Aging of mesenchymal stem cell in vitro. BMC Cell Biol 7: 14.
34. Yao CL, Chu IM, Hsieh TB, Hwang SM (2004) A systematic strategy to optimize ex vivo expansion medium for human hematopoietic stem cells derived from umbilical cord blood mononuclear cells. Exp Hematol 32: 720-727.
35. Liu CH, Hwang SM (2005) Cytokine interactions in mesenchymal stem cells from cord blood. Cytokine 32: 270-279.
36. Novotny NM, Markel TA, Crisostomo PR, Meldrum DR (2008) Differential IL-6 and VEGF secretion in adult and neonatal mesenchymal stem cells: role of NFkB. Cytokine 43: 215-219.
37. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, et al. (2005) Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer. Cell Tissue Res 319: 15-26.
38. Loges S, Fehse B, Brockmann MA, Lamszus K, Butzal M, et al. (2004) Identification of the adult human hemangioblast. Stem Cells Dev 13: 229-242.
39. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
40. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, et al. (2005) Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23: 1105-1112.
41. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S (2003) VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101: 168-172.
42. Poloni A, Rosini V, Mondini E, Maurizi G, Mancini S, et al. (2008) Characterization and expansion of mesenchymal progenitor cells from firsttrimester chorionic villi of human placenta. Cytotherapy 10: 690-697.
43. Baal N, Reisinger K, Jahr H, Bohle RM, Liang O, et al. (2004) Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood. Thromb Haemost 92: 767-775.
44. Nguyen VA, Furhapter C, Obexer P, Stossel H, Romani N, et al. (2009) Endothelial cells from cord blood CD133+CD34+ progenitors share phenotypic, functional and gene expression profile similarities with lymphatics. J Cell Mol Med 13: 522-534.
45. Fehrer C, Lepperdinger G (2005) Mesenchymal stem cell aging. Exp Gerontol 40: 926-930.
46. Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R (2009) Mesenchymal stem cells for clinical application. Vox Sang 98: 93-107.
47. Wagner W, Ho AD, Zenke M (2010) Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev 16: 445-453.
48. Aguayo-Mazzucato C, Bonner-Weir S (2010) Stem cell therapy for type 1 diabetes mellitus. Nat Rev Endocrinol 6: 139-148.
49. Harris DT (2008) Cord blood stem cells: a review of potential neurological applications. Stem Cell Rev 4: 269-274.
50. Macmillan ML, Blazar BR, DeFor TE, Wagner JE (2009) Transplantation of exvivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Bone Marrow Transplant 43: 447-454.
51. Sueblinvong V, Weiss DJ (2009) Cell therapy approaches for lung diseases: current status. Curr Opin Pharmacol 9: 268-273.
52. Zeddou M, Briquet A, Relic B, Josse C, Malaise MG, et al. (2010) The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biol Int 34: 693-701.